Ninomiya, Japan

Yasutaka Shimauchi


Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Kanagawa, JP (1985)
  • Ninomiya, JP (1982 - 1986)

Company Filing History:


Years Active: 1982-1986

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yasutaka Shimauchi: Innovator in Antibiotic Development

Introduction

Yasutaka Shimauchi is a notable inventor based in Ninomiya, Japan. He has made significant contributions to the field of antibiotic development, holding a total of six patents. His work focuses on enhancing the efficacy of macrolide antibiotics and developing novel compounds with improved antibacterial properties.

Latest Patents

One of Shimauchi's latest patents involves the creation of novel tylosin derivatives. These derivatives are represented by a specific formula where R can be a hydrogen atom, an acetyl group, or a propionyl group. The tylosin derivatives exhibit improved antibacterial activity and enhanced absorption and excretion in vivo. Another significant patent pertains to β-lactam derivatives, which includes a compound represented by a complex formula. This compound aims to provide a process for production that enhances the effectiveness of β-lactam antibiotics.

Career Highlights

Throughout his career, Yasutaka Shimauchi has worked with several companies, including Sanraku-Ocean Co., Ltd. and Sanraku Incorporated. His innovative work in antibiotic research has positioned him as a key figure in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Shimauchi has collaborated with notable coworkers such as Tomoyuki Ishikura and Takeo Yoshioka. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the development of his patented inventions.

Conclusion

Yasutaka Shimauchi's contributions to antibiotic development through his innovative patents highlight his importance in the field of pharmaceuticals. His work continues to influence the effectiveness of treatments available today.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…